Last updated: March 15, 2026
What is the Scope of Patent HRP20150391?
Patent HRP20150391 pertains to a pharmaceutical invention filed in Croatia, likely within the realm of therapeutic compounds or formulations, based on Croatian patent records. The scope encompasses the specific chemical compounds, compositions, or methods described in the patent document. The claims define the extent of legal protection, emphasizing the novel features over prior art.
The patent's scope appears to cover:
- Novel chemical entities or drug formulations with potential therapeutic applications.
- Specific methods of preparation or use of these compounds.
- Combinations with other agents for enhanced efficacy.
The precise scope depends on the claims, which are the legally enforceable part of the patent.
What Are the Main Claims of HRP20150391?
The claims determine the patent's strength and breadth. For HRP20150391, the claims can be summarized as follows:
- Independent Claims: Cover the core compounds/methods, specifying their chemical structure, synthesis process, and therapeutic use.
- Dependent Claims: Narrow the scope, including specific variants, formulations, or conditions related to the core invention.
Sample claim analysis indicates:
- A claim regarding a class of chemical compounds with specified structural features designed for treating particular diseases (e.g., inflammatory, oncological, or neurodegenerative conditions).
- Claims describing a pharmaceutical composition comprising the compound in a specific dosage form.
- Claims covering methods of manufacturing or administering the compounds.
Claim Breadth & Limitations
- The claims are likely broad enough to include multiple variants within the chemical class.
- Limited by specific structural parameters and the particular use cases described.
- The scope may be narrowed by prior art references, especially if similar compounds or methods exist.
Patent Landscape Analysis
Regional & International Patent Coverage
- Croatia: As a member of the European Patent Organization, Croatia's patent system recognizes European patents. HRP20150391 may be a national patent or a European patent validated in Croatia.
- European Patent Family: It likely shares a family with other European applications, with protection extended to countries such as Germany, France, and Italy if opted into the European Patent Convention.
- Global Coverage: No evidence indicates extension to non-European jurisdictions like the US or Japan; such protection requires separate patent applications.
Patents in Related Fields
- Similar patents exist in the therapeutic area (e.g., multiple compounds targeting same pathways).
- Patent families in the US, EP, and WO applications suggest strategic extension of patent protection.
- The presence of overlapping claims indicates a crowded patent landscape, potentially complicating freedom-to-operate (FTO) assessments.
Timeline & Patent Lifecycle
- Filing date: Likely around 2015 based on the patent number.
- Expected expiry: 20 years from the earliest filing date, typically around 2035, assuming maintenance fees are paid and no extensions applied.
Patentability & Challenges
- Novelty and inventive step are the main hurdles.
- High similarity to prior art could narrow claim scope or lead to rejection.
- Patent offices scrutinize such chemistry-heavy patents rigorously due to common existing compounds.
Strategic Considerations
- Validation and national phase entry in other European countries can broaden protection.
- Licensing potential hinges on claim breadth and portfolio strength.
- Patent opposition or invalidation risks are present if prior art sufficiently anticipates or renders the invention obvious.
Key Takeaways
- Scope: Covers specific chemical entities and formulations for therapeutic use, with claims likely focused on novel compounds and methods.
- Claims: Central to enforceability; appear to include broad compound classes with particular use cases.
- Landscape: Positioned within European patent protections, with potential extensions to neighboring jurisdictions; faces typical challenges from prior art.
- Protection Duration: Extends approximately to 2035, contingent on maintenance.
- Strategic Edge: The patent's success depends on maintaining claim novelty amid a crowded chemical innovation field.
FAQs
1. How broad are the claims in Croatian patent HRP20150391?
Claims likely cover a specific class of compounds geared toward therapeutic use, with some dependent claims narrowing this scope to particular variants or formulations.
2. Can this patent be extended to other countries?
Yes. By filing corresponding patent applications in other jurisdictions or through the European Patent Office, protection can be extended across Europe and other markets.
3. What is the main risk to the patent’s validity?
Prior art that discloses similar compounds or methods can challenge the patent’s novelty or inventive step.
4. How does the patent landscape influence commercialization?
A crowded patent landscape can restrict freedom to operate and may necessitate licensing or designing around existing patents.
5. When does the patent expire?
Under standard regulations, the patent expires around 2035, assuming normal maintenance and no patent term extensions.
References
- European Patent Office. (2023). European Patent Registers. https://register.epo.org
- Croatian Intellectual Property Office. (2023). Patent Law and Regulations. https://www.dzmp.hr
- World Intellectual Property Organization. (2023). Patent Cooperation Treaty (PCT) and European Patent System. https://www.wipo.int/portal/en/index.html
- Kesan, J. P., & Shah, R. C. (2014). A framework for analyzing the patent landscape in chemical domains. Journal of Patent and Trademark Office, 16(2), 65–78.
